Navigation Links
IDRI and Medicago announce authorization to initiate a Phase 1 clinical trial for an H5N1 vaccine
Date:8/16/2012

SEATTLE, WA, and QUEBEC CITY, QC, Aug. 16, 2012 The Infectious Disease Research Institute (IDRI), a Seattle-based non-profit research organization that is a leading developer of adjuvants used in vaccines combating infectious disease, and Medicago Inc. (TSX: MDG; OTCQX: MDCGF), a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), announce that they have been cleared by the U.S. Food and Drug Administration (FDA) to initiate a Phase 1 clinical trial for an H5N1 Avian Influenza VLP vaccine candidate ("H5N1 vaccine"). This is an important step toward development of an influenza vaccine that could be rapidly and widely administered in case of a pandemic flu outbreak. The trial is focused on evaluating the safety and immunogenicity of the H5N1 vaccine, combined with IDRI's Glucopyranosyl Lipid A ("GLA") adjuvant, which will be administered intramuscularly or intradermally. Each study participant in the trial will receive two doses of a given formulation in order to collect and compare data.

The trial is believed to be the first human test of an intradermal adjuvant a technology platform that could potentially benefit a number of worldwide vaccination programs and could result in a vaccine that could be self-administered in case of a pandemic. "A massive flu outbreak would cause a strain on health care centers as people rush to get a vaccination," said Darrick Carter, Ph.D., Vice President of IDRI's Adjuvant Technology program and co-principal investigator for the project. "Our idea is to ultimately produce a one-dose vaccine that you could give yourself imagine a flu vaccine that you can easily administer using a simple, painless microneedle device arriving in your mailbox."

"This research collaboration may provide for expedited vaccination and greater ease of use in the event of an influenza pandemic," said Andy Sheldon, Pr
'/>"/>

Contact: Lee Schoentrup
lee.schoentrup@idri.com
206-518-6290
Infectious Disease Research Institute
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. NYU School of Medicine announces new clinical trial for ulcerative colitis
2. SU2C, Dutch Cancer Society announce new International Translational Cancer Research Grant recipients
3. Swaziland HIV incidence results announced at AIDS 2012
4. Mayo Clinic, Dartmouth-Hitchcock announce collaboration
5. ASTRO announces 2012 fellows class
6. Wolters Kluwer Health and the Transplantation Society announce a partnership
7. Keystone Symposia announces new 3-year grant to tackle major global health challenges
8. Elsevier announces publishing the Journal of Hospitality, Leisure, Sport and Tourism Education
9. MindSpec announces Bridging Parents with Autism Science webinar series
10. New grants for innovative Alzheimers disease research announced by AHAF
11. Heuer M.D. Research Announces CardiaShred™ - First Medical Doctor Formulated, Heart Healthy Weight Loss, Energy and Lean Muscle Building Supplement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... ... September 01, 2015 , ... ... to announce its new fall collection. Every customer who buys an Earth Brand ... the company’s environmental partnership with Trees for the Future, a nonprofit dedicated to ...
(Date:9/1/2015)... ... ... Celebrity hairstylist and Beauty Gives Back Art Team member Ted Gibson in ... Oct. 1, at the La Valencia Hotel. The presentation, on the eve of Fashion ... professional hair, makeup and nail design. , The evening of beauty and fashion ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... options to efficiently cure and prevent different malignancies. Some options for cancer ... pathophysiological properties due to which distinctive approach is necessary for effective treatment. ...
(Date:9/1/2015)... ... September 01, 2015 , ... Virginia ... Machine,” is still strongly maintaining her firm’s success in the hair care and ... her upcoming city-to-city tour, Ellis will be providing “Look and learn” live demonstrations, ...
(Date:9/1/2015)... ... 01, 2015 , ... PetPace, the provider of an innovative ... activity, today announced its integration with leading veterinary Practice Management Software vendor Cornerstone. ... Practice Management Software packages in the US. Practice Management Software helps veterinarians manage ...
Breaking Medicine News(10 mins):Health News:Earth Brands Footwear Partners with Trees for the Future for Launch of Fall Collection: Buy Shoes, Plant a Tree 2Health News:Earth Brands Footwear Partners with Trees for the Future for Launch of Fall Collection: Buy Shoes, Plant a Tree 3Health News:Celebrity Hairstylist Ted Gibson Explores Fusion of Fashion and Beauty at “Beauty Behind the Fashion” at Fashion Week San Diego Proceeds to benefit THIRST Project 2Health News:Celebrity Hairstylist Ted Gibson Explores Fusion of Fashion and Beauty at “Beauty Behind the Fashion” at Fashion Week San Diego Proceeds to benefit THIRST Project 3Health News:CD Antigen Cancer Market and Pipeline Landscape Examined in Comprehensive Kuick Research Report Published at MarketPublishers.com 2Health News:CD Antigen Cancer Market and Pipeline Landscape Examined in Comprehensive Kuick Research Report Published at MarketPublishers.com 3Health News:Beauty Entrepreneur creates hair extension smart machine and mobile app inspired by UBER technology 2Health News:Petpace-Cornerstone Integration Lowers Overhead, Raises Data Visibility for Veterinary Practices 2
... powers introduced by the government to enable specially trained ... been successfully adopted, according to a new report. ... Keele found widespread acceptance of the new powers among ... for the type of medical conditions being treated. ...
... HealthDay Reporter , MONDAY, May 9 (HealthDay News) -- ... nervous system disease known as amyotrophic lateral sclerosis (ALS), British ... does not mean people with long ring fingers will develop ... risk for it. "We have not done a study ...
... By Alan Mozes HealthDay Reporter , MONDAY, ... link specific behaviors and health conditions to the onset of ... anything you do or don,t do will prevent the brain ... The U.S. National Institutes of Health convened a ...
... at Scripps Institution of Oceanography at UC San Diego ... known to produce substances potentially useful against human diseases. ... the oldest forms of life on the planet. At ... to humans and animals. But despite the recognized capability ...
... MONDAY, May 9 (HealthDay News) -- Could gastric bypass weight-loss ... That,s the finding from a group of Swedish researchers who ... the Digestive Disease Week conference in Chicago. A team ... patients who underwent primary bariatric surgery between 1980 and 2006. ...
... MONDAY, May 9 (HealthDay News) -- Overdiagnosis and overtreatment of ... to the large increase in the use of computed tomography ... embolism (PE) is a potentially life-threatening blood clot in the ... PE and its use has grown rapidly, according to background ...
Cached Medicine News:Health News:Wide-reaching report finds strong support for nurse and pharmacist prescribing 2Health News:Ring Finger Length Linked to ALS, Study Suggests 2Health News:Ring Finger Length Linked to ALS, Study Suggests 3Health News:Little Evidence That Diet, Lifestyle Cuts Alzheimer's Risk 2Health News:Little Evidence That Diet, Lifestyle Cuts Alzheimer's Risk 3Health News:Genome of marine organism reveals hidden secrets 2Health News:Genome of marine organism reveals hidden secrets 3Health News:Risk for Problem Drinking May Rise After Gastric Bypass 2Health News:Scan Technology Tied to Overtreatment of Clots in Lungs 2
(Date:9/1/2015)... --NOWDiagnostics Inc., based in Springdale, Ark. , ... Canada , a move that brings the company ... have greater access to information concerning their health. ... blood-based rapid tests that allow health care providers to ... ailments and diseases. ZBx Corporation, a Toronto ...
(Date:9/1/2015)... , Sept. 1, 2015  Dr. Cindy ... Labs , the cannabis testing subsidiary of DigiPath, Inc. ... Group about the lack of consistency in today,s ... online resource for medical cannabis information, she explained that ... because their lack of uniform requirements makes standardization impossible. ...
(Date:9/1/2015)... 1, 2015   Alpha Imaging LLC , a leading distributor ... announced today that they have been awarded exclusive rights to ... in Michigan.   The new territory supplements Alpha Imaging,s existing Shimadzu sales ... Ohio , Indiana , ... , West Virginia , Delaware ...
Breaking Medicine Technology:NOWDiagnostics Inc. Acquires Canada's ZBx Corporation 2NOWDiagnostics Inc. Acquires Canada's ZBx Corporation 3DigiPath Labs CSO Dr. Cindy Orser Calls for Uniform Standards for Cannabis Safety Testing 2DigiPath Labs CSO Dr. Cindy Orser Calls for Uniform Standards for Cannabis Safety Testing 3Alpha Imaging Expands Shimadzu Territory 2
... Medical Systems (NYSE: VAR ) today announced that ... N.A. to repurchase $250 million of its common stock under ... revolving credit facility with Bank of America, N.A. to increase ... Under the accelerated repurchase agreement, Varian will pay $250 ...
... Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) today announced ... trial evaluating the safety and pharmacokinetics of dabigatran ... valves.(1) The 12-week study will compare three doses ... 300mg bid) to warfarin in patients with both ...
Cached Medicine Technology:Varian Medical Systems Announces $250 Million Accelerated Stock Repurchase; Increases Its Revolving Credit Facility 2Varian Medical Systems Announces $250 Million Accelerated Stock Repurchase; Increases Its Revolving Credit Facility 3Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 2Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 3Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 4Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 5Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 6Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 7
... a whole blood hematology control manufactured specifically ... 120, and the Coulter AcT5diff instruments. The ... white cell differential, positioning the populations within ... systems. The product offers 105-day closed-vial stability ...
... assayed hematology control, offers complete assay values ... with the Coulter GENS, STKS, MAXM and ... stability, 105-day closed-vial stability and is available ... 4.0ml pierceable cap vial is compatible with ...
Abiomed introduces its new intra-aortic balloon (IAB); an easy-to-insert, minimally invasive technology designed to enhance blood flow to the heart and other organs for patients with diminished heart...
Diagnosoft HARP is designed for rapid analysis of tagged cardiac MR images using the HARP technology, which is packaged into an intuitive, easy-to-use graphic user interface....
Medicine Products: